FORMULATION OF CATECHOLAMINES FOR EXTERNAL USE

FORMULATION OF CATECHOLAMINES FOR EXTERNAL USE

PURPOSE:To obtain a formulation for external use, containing catecholamines, a medium-chain fatty acid glyceride and surfactant in a buffer solution containing a stabilizer, having excellent skin permeability, readily regulating dose as well as excellent in usefulness and safety. CONSTITUTION:A form...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: OKUMURA MUTSUO, UKIGAYA TADASHI
Format: Patent
Sprache:eng
Schlagworte:
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator OKUMURA MUTSUO
UKIGAYA TADASHI
description PURPOSE:To obtain a formulation for external use, containing catecholamines, a medium-chain fatty acid glyceride and surfactant in a buffer solution containing a stabilizer, having excellent skin permeability, readily regulating dose as well as excellent in usefulness and safety. CONSTITUTION:A formulation for external use obtained by blending 0.1-50.0wt% catecholamines, 1.0-30.0wt% medium-chain fatty acid glyceride and 0.05-1.0wt% surfactant, e.g. sorbitan ester of a fatty acid, in a buffer solution, containing a stabilizer, e.g. sodium hydrogensulfite or cysteine hydrochloride, and adjusted to pH3.5-6.5. Adrenaline isoproterenol, etc., are used as the catecholamines and monoglyceride, diglyceride or a 6-18C fatty acid, etc., are used as the medium-chain fatty acid glyceride. The formulation for external use is useful for treating bronchial asthma, etc., and sustained administration can be carried out.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_JPS63107916A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>JPS63107916A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_JPS63107916A3</originalsourceid><addsrcrecordid>eNrjZNBz8w_yDfVxDPH091Pwd1Nwdgxxdfbw93H09fRzDVYAyiq4RoS4Bvk5-iiEBrvyMLCmJeYUp_JCaW4GRTfXEGcP3dSC_PjU4oLE5NS81JJ4r4BgM2NDA3NLQzNHY2LUAAD5ECYr</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>FORMULATION OF CATECHOLAMINES FOR EXTERNAL USE</title><source>esp@cenet</source><creator>OKUMURA MUTSUO ; UKIGAYA TADASHI</creator><creatorcontrib>OKUMURA MUTSUO ; UKIGAYA TADASHI</creatorcontrib><description>PURPOSE:To obtain a formulation for external use, containing catecholamines, a medium-chain fatty acid glyceride and surfactant in a buffer solution containing a stabilizer, having excellent skin permeability, readily regulating dose as well as excellent in usefulness and safety. CONSTITUTION:A formulation for external use obtained by blending 0.1-50.0wt% catecholamines, 1.0-30.0wt% medium-chain fatty acid glyceride and 0.05-1.0wt% surfactant, e.g. sorbitan ester of a fatty acid, in a buffer solution, containing a stabilizer, e.g. sodium hydrogensulfite or cysteine hydrochloride, and adjusted to pH3.5-6.5. Adrenaline isoproterenol, etc., are used as the catecholamines and monoglyceride, diglyceride or a 6-18C fatty acid, etc., are used as the medium-chain fatty acid glyceride. The formulation for external use is useful for treating bronchial asthma, etc., and sustained administration can be carried out.</description><language>eng</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>1988</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=19880512&amp;DB=EPODOC&amp;CC=JP&amp;NR=S63107916A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76516</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=19880512&amp;DB=EPODOC&amp;CC=JP&amp;NR=S63107916A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>OKUMURA MUTSUO</creatorcontrib><creatorcontrib>UKIGAYA TADASHI</creatorcontrib><title>FORMULATION OF CATECHOLAMINES FOR EXTERNAL USE</title><description>PURPOSE:To obtain a formulation for external use, containing catecholamines, a medium-chain fatty acid glyceride and surfactant in a buffer solution containing a stabilizer, having excellent skin permeability, readily regulating dose as well as excellent in usefulness and safety. CONSTITUTION:A formulation for external use obtained by blending 0.1-50.0wt% catecholamines, 1.0-30.0wt% medium-chain fatty acid glyceride and 0.05-1.0wt% surfactant, e.g. sorbitan ester of a fatty acid, in a buffer solution, containing a stabilizer, e.g. sodium hydrogensulfite or cysteine hydrochloride, and adjusted to pH3.5-6.5. Adrenaline isoproterenol, etc., are used as the catecholamines and monoglyceride, diglyceride or a 6-18C fatty acid, etc., are used as the medium-chain fatty acid glyceride. The formulation for external use is useful for treating bronchial asthma, etc., and sustained administration can be carried out.</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>1988</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZNBz8w_yDfVxDPH091Pwd1Nwdgxxdfbw93H09fRzDVYAyiq4RoS4Bvk5-iiEBrvyMLCmJeYUp_JCaW4GRTfXEGcP3dSC_PjU4oLE5NS81JJ4r4BgM2NDA3NLQzNHY2LUAAD5ECYr</recordid><startdate>19880512</startdate><enddate>19880512</enddate><creator>OKUMURA MUTSUO</creator><creator>UKIGAYA TADASHI</creator><scope>EVB</scope></search><sort><creationdate>19880512</creationdate><title>FORMULATION OF CATECHOLAMINES FOR EXTERNAL USE</title><author>OKUMURA MUTSUO ; UKIGAYA TADASHI</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_JPS63107916A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>1988</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>OKUMURA MUTSUO</creatorcontrib><creatorcontrib>UKIGAYA TADASHI</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>OKUMURA MUTSUO</au><au>UKIGAYA TADASHI</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>FORMULATION OF CATECHOLAMINES FOR EXTERNAL USE</title><date>1988-05-12</date><risdate>1988</risdate><abstract>PURPOSE:To obtain a formulation for external use, containing catecholamines, a medium-chain fatty acid glyceride and surfactant in a buffer solution containing a stabilizer, having excellent skin permeability, readily regulating dose as well as excellent in usefulness and safety. CONSTITUTION:A formulation for external use obtained by blending 0.1-50.0wt% catecholamines, 1.0-30.0wt% medium-chain fatty acid glyceride and 0.05-1.0wt% surfactant, e.g. sorbitan ester of a fatty acid, in a buffer solution, containing a stabilizer, e.g. sodium hydrogensulfite or cysteine hydrochloride, and adjusted to pH3.5-6.5. Adrenaline isoproterenol, etc., are used as the catecholamines and monoglyceride, diglyceride or a 6-18C fatty acid, etc., are used as the medium-chain fatty acid glyceride. The formulation for external use is useful for treating bronchial asthma, etc., and sustained administration can be carried out.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng
recordid cdi_epo_espacenet_JPS63107916A
source esp@cenet
subjects HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title FORMULATION OF CATECHOLAMINES FOR EXTERNAL USE
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-14T23%3A11%3A40IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=OKUMURA%20MUTSUO&rft.date=1988-05-12&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EJPS63107916A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true